Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Yanlin Song, Zhenfei Bi, Yu Liu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 1, pp. 76-88
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 224
The current landscape of the antimicrobial peptide melittin and its therapeutic potential
Hai-Qian Zhang, Chengbiao Sun, Na Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 28
Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
The impact of ribosome biogenesis in cancer: from proliferation to metastasis
Sseu-Pei Hwang, Catherine Denicourt
NAR Cancer (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 19
Multiple myeloma: signaling pathways and targeted therapy
Qizhong Lu, Donghui Yang, Hexian Li, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 17
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 470-470
Open Access | Times Cited: 15
New Directions in the Therapy of Glioblastoma
Katarzyna Szklener, Marek Mazurek, Małgorzata Wieteska, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5377-5377
Open Access | Times Cited: 56
Navigating the ERK1/2 MAPK Cascade
Ana Martín-Vega, Melanie H. Cobb
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1555-1555
Open Access | Times Cited: 35
Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species
Songhyun Ju, Manish Kumar Singh, Sunhee Han, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12387-12387
Open Access | Times Cited: 10
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Precision medicine in gynecological cancer (Review)
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access | Times Cited: 1
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 6
Exploring Small-Molecule Inhibitors Targeting MAPK Pathway Components: Focus on ERK, MEK1, and MEK2 Kinases in Cancer Treatment
Tuhin Mukherjee, Satyajit Mohanty, Jasleen Kaur, et al.
Chemical Biology Letters (2024) Vol. 11, Iss. 2, pp. 659-659
Open Access | Times Cited: 6
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6
In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation
Mehreen Ghufran, Haider Ali Khan, Mehran Ullah, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4884-4884
Open Access | Times Cited: 23
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Mcl-1 Protein and Viral Infections: A Narrative Review
Zbigniew Wyżewski, Justyna Stępkowska, Aleksandra Maria Kobylińska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1138-1138
Open Access | Times Cited: 5
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
Malathi Kandarpa, Dan R. Robinson, Yi‐Mi Wu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1972-1983
Open Access | Times Cited: 5
Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA)
Firas Kreidieh, Jennifer L. McQuade
American Heart Journal Plus Cardiology Research and Practice (2024) Vol. 40, pp. 100374-100374
Open Access | Times Cited: 5
Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
Mohammad Ebrahimnezhad, Amir Valizadeh, Maryam Majidinia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116833-116833
Open Access | Times Cited: 5
Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma
Babita Shashni, Hao Thi Tran, Long Binh Vong, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 50-50
Open Access
The long isoform of PRLR promotes tumor progression by regulating CDK6 through MAPK signal pathway in SHH medulloblastoma
Ziwen Sun, Haishuang Li, Yu Peng, et al.
Research Square (Research Square) (2025)
Open Access
Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
Shaimaa Khattab, Adriatik Berisha, Natalia Baran, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 202-202
Open Access
Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting
Guoshuai Xu, Qinghong Zhang, R. Holland Cheng, et al.
Autophagy (2025)
Open Access
It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma
Rebeca Yakubov, Ramneet Kaloti, Phooja Persaud, et al.
Journal of Neuro-Oncology (2025)
Open Access
Page 1 - Next Page

Scroll to top